Endoscopy
DOI: 10.1055/a-2619-4638
Original article

Prospective analysis of endoscopic impedance planimetry pyloric measurements and its association with clinical outcomes with gastric peroral endoscopic myotomy

Aimen Farooq
1   Gastroenterology, AdventHealth Central Florida, Orlando, United States (Ringgold ID: RIN558924)
2   AdventHealth Orlando, Orlando, United States (Ringgold ID: RIN440172)
,
BahaAldeen Bani Fawwaz
1   Gastroenterology, AdventHealth Central Florida, Orlando, United States (Ringgold ID: RIN558924)
,
Yiyang Zhang
3   Statistics, AdventHealth Central Florida, Orlando, United States (Ringgold ID: RIN558924)
,
Muhammad Khalid Hasan
4   Center for Interventional Endoscopy, Florida Hospital Orlando, Orlando, United States (Ringgold ID: RIN6244)
,
Arooj Mian
5   Internal Medicine, AdventHealth Central Florida, Orlando, United States (Ringgold ID: RIN558924)
,
Hafiz Muzaffar Akbar Khan
6   Gastroenterology and Hepatology, Staten Island University Hospital, Staten Island, United States (Ringgold ID: RIN7601)
,
Tony S Brar
7   Center for Interventional Endoscopy, AdventHealth Orlando, Orlando, United States (Ringgold ID: RIN440172)
,
Sanmeet Singh
1   Gastroenterology, AdventHealth Central Florida, Orlando, United States (Ringgold ID: RIN558924)
,
Artur Viana
1   Gastroenterology, AdventHealth Central Florida, Orlando, United States (Ringgold ID: RIN558924)
,
Maham Hayat
8   Center for Interventional Endoscopy, AdventHealth Central Florida, Orlando, United States (Ringgold ID: RIN558924)
,
Yasi Xiao
9   Gastroenterology, Thomas Jefferson University Hospitals, Wayne, United States (Ringgold ID: RIN6529)
,
Waleed Aljohani
10   Gastroenterology, AdventHealth GME, Orlando, United States (Ringgold ID: RIN644690)
,
Abdullah Abbasi
11   Gastroenterology, AdventHealth Orlando, Orlando, United States (Ringgold ID: RIN440172)
,
Saurabh Chandan
7   Center for Interventional Endoscopy, AdventHealth Orlando, Orlando, United States (Ringgold ID: RIN440172)
,
Sagar Pathak
7   Center for Interventional Endoscopy, AdventHealth Orlando, Orlando, United States (Ringgold ID: RIN440172)
,
Kambiz Kadkhodayan
7   Center for Interventional Endoscopy, AdventHealth Orlando, Orlando, United States (Ringgold ID: RIN440172)
,
Mustafa A Arain
7   Center for Interventional Endoscopy, AdventHealth Orlando, Orlando, United States (Ringgold ID: RIN440172)
,
Natalie Cosgrove
12   Center For Interventional Endoscopy, AdventHealth Orlando, Orlando, United States (Ringgold ID: RIN440172)
,
Deepanshu Jain
12   Center For Interventional Endoscopy, AdventHealth Orlando, Orlando, United States (Ringgold ID: RIN440172)
,
Irteza Inayat
1   Gastroenterology, AdventHealth Central Florida, Orlando, United States (Ringgold ID: RIN558924)
,
Dennis Yang
7   Center for Interventional Endoscopy, AdventHealth Orlando, Orlando, United States (Ringgold ID: RIN440172)
› Author Affiliations
Clinical Trial: Registration number (trial ID): NCT05905016, Trial registry: ClinicalTrials.gov (http://www.clinicaltrials.gov/), Type of Study: Prospective

Background and Aims: Functional luminal imaging probe (FLIP) assesses pyloric sphincter physiology. We aimed to prospectively use FLIP to evaluate the association between pyloric measurements and clinical outcomes of gastric peroral endoscopic myotomy (G-POEM) in patients with refractory gastroparesis. Methods: Single-center prospective trial of patients who underwent G-POEM between January 2022 and March 2024. FLIP was performed pre-G-POEM, immediately post-G-POEM and at follow-up (median 6 months). Clinical response was defined as an improvement of ≥ 1 point on the Gastroparesis Cardinal Symptom Index (GCSI). Receiver operating characteristic curve was constructed to evaluate the relationship between FLIP measurements and response to G-POEM. Results: Clinical response was achieved in 64 out of 90 (71.1%) at a median of 6-months. Pre-G-POEM FLIP mean distensibility index (DI) was significantly lower among responders vs. non-responders (7.1±2.8 vs. 9.2±3.1 mm2/mm Hg; p=0.002). Mean DI increased significantly in both groups immediately after G-POEM, but this remained persistently elevated only among responders (10.4±4.4 mm2/mm Hg; p=0.02), while returning towards baseline among non-responders (9.7±4.7 mm2/mm Hg; p=0.69) at 6-month follow-up. Pre-G-POEM DI with an area under the curve of 0.72 yielded a specificity of 80.8% and sensitivity of 60.6% at a cut-off point of 7.35 mm2/mm Hg. Conclusion: Sustained improvement in pyloric FLIP measurements was seen in patients who endorsed a clinical response to G-POEM. Patients who responded to G-POEM had a lower baseline DI when compared to non-responders. Additional studies optimizing and standardizing FLIP protocols in patients undergoing G-POEM are needed.



Publication History

Received: 06 January 2025

Accepted after revision: 22 May 2025

Accepted Manuscript online:
22 May 2025

© . Thieme. All rights reserved.

Georg Thieme Verlag KG
Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany